Drug Profile
SL 880338
Alternative Names: SL880338-08Latest Information Update: 07 Jan 1997
Price :
$50
*
At a glance
- Originator Sanofi-Synthelabo
- Class Antidepressants; Antiemetics; Antihypertensives; Antimigraines; Anxiolytics; Sleep disorder therapies
- Mechanism of Action 5-HT1A serotonin receptor inverse agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Major depressive disorder; Sleep disorders
Most Recent Events
- 07 Jan 1997 Discontinued-Preclinical for Depression in France (Unknown route)
- 07 Jan 1997 Discontinued-Preclinical for Sleep disorders in France (Unknown route)
- 14 Feb 1995 Discontinued-Preclinical for Anxiety disorders in France (Unknown route)